Cystos 125mcg Injection
Marketer
Vhb Life Sciences Inc
Salt Composition
Carboprost (125mcg)
Overview Cystos 125mcg Injection
Postpartum uterine hemorrhage is managed with Cystos 125mcg Injection, a medication that promotes uterine muscle contractions to reduce bleeding. Administered intramuscularly by a physician in a hospital setting only, self-injection is strictly prohibited. Common side effects, including nausea, facial flushing, headache, and shivering, should be reported to your doctor if they become severe. Dizziness warrants avoidance of driving and activities requiring focus. Prior to treatment, disclose any history of cardiac conditions, hypertension, hypotension, hepatic or renal impairment, and all other medications currently in use, as interactions may affect Cystos' efficacy. This injection is exclusively for postpartum use; it is contraindicated during pregnancy.
Primary Ingredients of Cystos 125mcg Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Cystos 125mcg Injection
Hemorrhage postpartum
Major Benefits of Cystos 125mcg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Cystos 125mcg Injection:
- Nausea
- Vomiting
- Headache
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Hot flashes
- Diarrhea
- Chills
- Placental retention
- Cough
How to use Cystos 125mcg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Cystos 125mcg Injection works:
Uterine muscle contraction is induced by Cystos 125mcg Injection, thus aiding in postpartum hemorrhage management.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Cystos 125mcg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyUNSAFE
Administration of Cystos 125mcg Injection is contraindicated during gestation. Pregnant individuals should consult their physician; research in animal models and human pregnancies indicates substantial adverse effects on fetal development.
Breast feedingCAUTION
Administering Cystos 125mcg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the treatment period and until the medication is fully cleared from their system.
DrivingUNSAFE
Administering Cystos 125mcg Injection may induce adverse reactions that impair driving capabilities. This is because Cystos 125mcg Injection can cause dizziness, drowsiness, or loss of consciousness, thereby affecting the ability to operate a vehicle safely.
KidneyCAUTION
Patients with impaired kidney function should use Cystos 125mcg Injection cautiously, potentially requiring a modified dosage. Physician consultation is advised. Cystos 125mcg Injection is contraindicated in individuals experiencing active kidney disease.
LiverCAUTION
Patients with liver impairment should use Cystos 125mcg Injection cautiously, potentially requiring dosage modification. Physician consultation is advised. Cystos 125mcg Injection is contraindicated in individuals experiencing active liver disease.
What if you forget to take Cystos 125mcg Injection :
NA
Facts to Know About Cystos 125mcg Injection
| Label | Value |
|---|---|
| Chemical Classification | Prostaglandin Analog |
| Developing Habits | No. |
| Treatment Category | Obstetrics and Gynecology |
3,018 People bought this recently